CLINICAL_TRIALS
trial_result
· 2023-04-27
Clinical Trial Update: A Study of the Efficacy and Safety of Pexidartinib in Adult Subjects With TGCT [Phase 3]
Summary
Phase 3 study evaluating the efficacy and safety of pexidartinib in adults with Tenosynovial Giant Cell Tumor; results were posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daiichi Sankyo Co., Ltd. | Conditions: Tenosynovial Giant Cell Tumor | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-04-27